h, development, marketing and distribution of probiotics dietary
supplements. Through its wholly owned subsidiary, Shanghai Shining
Biotechnology Co., Ltd., the Company has operations in Shanghai. Its
proprietary product portfolio contains live microbial nutritional
supplements under the "Shining" brand. Currently, the products are sold OTC
through large distributors to pharmacies and supermarkets in Shanghai,
Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand
stores in major cities in China. Currently, China-Biotics is strategically
expanding its production capacity of probiotics to meet growing demand in
the bulk additive market. For more information, please visit
http://www.chn-biotics.com .
Safe Harbor Statement Under the Private Securities Litigation Reform
Act of 1995: Any statements set forth above that are not historical facts
are forward-looking statements that involve risks and uncertainties that
could cause actual results to differ materially from those in the
forward-looking statements. Such factors include, but are not limited to,
the Company's ability to market existing and new products, ability to
access capital for expansion, and changes from anticipated levels of sales,
future national or regional economic and competitive conditions, market
acceptance of its retail store concept, changes in relationships with
customers, dependence on its flagship product profits and other factors
detailed from time to time in the Company's filings with the United States
Securities and Exchange Commission and other regulatory authorities. The
Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.
CHINA-BIOTICS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts expressed in
'/>"/>
SOURCE China-Biotics, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Related biology technology :1.
China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 20082.
China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results3.
China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company4.
China-Biotics, Inc. to Present at Two Upcoming Investor Conferences5.
China-Biotics, Inc. Completes Foundation for Its New Plant6.
China-Biotics, Inc. Reports Third Quarter 2008 Financial Results7.
China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results8.
China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site9.
China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results10.
China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility11.
China-Biotics, Inc. Launches Shining Probiotics Protein Powder